| Abeona Therapeutics, Inc. | Common | $9.7M | 0.6%Prev: 0.8% | 1,842,751 SH | Decreased |
| Abivax SA - ADR | SPONSORED ADS | $48.5M | 3.1%Prev: 2.5% | 359,305 SH | Increased |
| Aclaris Therapeutics, Inc. | Common | $26.8M | 1.7%Prev: 1.4% | 8,888,888 SH | Increased |
| Alto Neuroscience Inc | Common | $18.4M | 1.2% | 1,035,551 SH | New |
| Avadel Pharmaceuticals PLC | ADR | $57.8M | 3.7%Prev: 3.3% | 2,684,109 SH | Increased |
| Bolt Therapeutics Inc | Common | $396K | 0.0%Prev: 0.1% | 72,414 SH | Decreased-103,650 SH |
| Bright Minds Biosciences Inc | Common | $39.1M | 2.5%Prev: 2.4% | 501,617 SH | Increased |
| CAMP4 Therapeutics Inc | Common | $26.0M | 1.7%Prev: 0.9% | 4,246,568 SH | Increased+325,000 SH |
| Cidara Therapeutics, Inc. | Common | $211.3M | 13.7%Prev: 10.1% | 956,670 SH | Increased-354,755 SH |
| Cogent Biosciences Inc | Common | $85.2M | 5.5%Prev: 3.2% | 2,398,993 SH | Increased-390,144 SH |
| Compass Therapeutics Inc | Common | $51.3M | 3.3%Prev: 2.7% | 9,545,466 SH | Increased |
| Corvus Pharmaceuticals Holdings | Common | $17.2M | 1.1%Prev: 1.3% | 2,234,566 SH | Increased |
| Cytomx Therapeutics Inc | Common | $12.3M | 0.8%Prev: 0.7% | 2,884,615 SH | Increased |
| DBV Technologies SA | SPONSORED ADS | $47.2M | 3.1%Prev: 0.8% | 2,461,626 SH | Increased+1,407,120 SH |
| Design Therapeutics Inc | Common | $15.1M | 1.0% | 1,612,903 SH | New |
| Dianthus Therapeutics Inc | Common | $14.6M | 0.9%Prev: 1.1% | 353,998 SH | Increased |
| Dyne Therapeutics Inc | Common | $51.1M | 3.3%Prev: 2.7% | 2,614,960 SH | Increased |
| EnGene Holdings Inc | Warrants | $844K | 0.1% | 285,046 SH | New |
| Erasca Inc | Common | $34.5M | 2.2%Prev: 1.6% | 9,273,428 SH | Increased |
| Eupraxia Pharmaceuticals Inc | Common | $10.2M | 0.7%Prev: 0.6% | 1,350,000 SH | Increased |
| Geron Corp | Common | $35.9M | 2.3%Prev: 3.0% | 27,225,292 SH | Decreased |
| Instil Bio Inc | Common | $3.2M | 0.2%Prev: 0.4% | 292,743 SH | Decreased |
| LB Pharmaceuticals Inc | Common | $17.8M | 1.2%Prev: 1.0% | 800,000 SH | Increased |
| Minerva Neurosciences Inc | Common | $17.4M | 1.1% | 4,322,747 SH | New |
| Monopar Therapeutics Inc | Common | $5.9M | 0.4%Prev: 0.6% | 90,500 SH | Decreased |
| Moonlake Immunotherapeutics | Common | $13.2M | 0.9% | 1,000,000 SH | New |
| Olema Pharmaceuticals Inc | Common | $16.8M | 1.1%Prev: 1.2% | 671,843 SH | Increased-834,019 SH |
| Oric Pharmaceuticals Inc | Common | $17.3M | 1.1%Prev: 3.0% | 2,118,384 SH | Decreased-1,008,220 SH |
| Palisade Bio Inc | Common | $5.4M | 0.3% | 2,293,578 SH | New |
| Pasithea Therapeutics Corp | Common | $2.7M | 0.2% | 2,100,000 SH | New |
| Pepgen Inc | Common | $15.1M | 1.0%Prev: 0.9% | 2,325,000 SH | Increased |
| Praxis Precision Medicines | Common | $96.9M | 6.3%Prev: 0.8% | 328,895 SH | Increased+130,000 SH |
| Precision Biosciences Inc | Common | $19K | 0.0%Prev: 0.0% | 4,675 SH | Decreased |
| SAB Biotherapeutics Inc | Common | $42.7M | 2.8%Prev: 1.8% | 11,420,000 SH | Increased |
| Sera Prognostics Inc | Common | $4.9M | 0.3%Prev: 0.4% | 1,650,440 SH | Decreased |
| Silence Therapeutics PLC | ADS | $6.7M | 0.4%Prev: 0.5% | 1,105,454 SH | Increased |
| Sinovac Biotech Ltd. | SHS | $38.2M | 2.5%Prev: 3.1% | 5,903,000 SH | |
| Soleno Therapeutics Inc | Common | $41.4M | 2.7%Prev: 12.4% | 894,909 SH | Decreased-1,383,294 SH |
| Surrozen Inc | Common | $5.9M | 0.4%Prev: 0.3% | 260,000 SH | Increased |
| Tango Therapeutics Inc | Common | $19.1M | 1.2%Prev: 0.5% | 2,154,780 SH | Increased+1,378,081 SH |
| Tenax Therapeutics Inc | Common | $2.5M | 0.2%Prev: 0.1% | 208,333 SH | Increased |
| Terns Pharmaceuticals Inc | Common | $216.0M | 14.0%Prev: 4.2% | 5,346,928 SH | Increased-1,548,818 SH |
| Trevi Therapeutics Inc | Common | $63.8M | 4.1%Prev: 3.8% | 5,094,668 SH | Increased |
| Unicycive Therapeutics | Common | $10.3M | 0.7%Prev: 0.6% | 1,789,916 SH | Increased |
| Verastem Inc | Common | $8.5M | 0.6%Prev: 1.9% | 1,106,524 SH | Decreased-1,538,461 SH |
| Viridian Therapeutics Inc | Common | $30.6M | 2.0%Prev: 1.7% | 982,576 SH | Increased |
| Zenas Biopharma Inc | Common | $31.0M | 2.0%Prev: 2.1% | 853,495 SH | Increased-329,765 SH |